liminatuspharma.com - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi LIMN
Liminatus Pharma is investing in R&D for gastrointestinal tumor vaccines while the market awaits the start of clinical trials. The company's absolute operating profit in cash demonstrates real cash flow, where the value of 0.00 reflects this status. Recruiting leading oncologists to develop CAR-T therapy provides the scientific foundation for the issuer's future success.
Liminatus Pharma LLC - rincian analitis lan metrik utama (LIMN)
- nilai pasar lan prakiraan target analis:
- rincian nilai pasar emiten:
- informasi kapitalisasi buku:
- rincian struktur utang lan likuiditas bisnis:
Rasio Total Utang marang Ekuitas Liminatus Pharma|LIMN - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Liminatus Pharma Inc.|LIMN - Utang perusahaan|Rasio utang marang nilai buku Liminatus Pharma|LIMN - Utang jangka dawa perusahaan|Utang jangka cendhak Liminatus Pharma|Likuiditas kritis liminatuspharma.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
LIMN - Penghasilan resik|Bathi resik mangsa ngarep Liminatus Pharma|LIMN - Pangali P/E|Pangali mangsa ngarep rega marang bathi liminatuspharma.com|LIMN - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Liminatus Pharma|LIMN - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Liminatus Pharma|LIMN - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan liminatuspharma.com|LIMN - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Liminatus Pharma
Analisis kabeh metrik perusahaan:Liminatus - LIMN
Diversifying its cell therapy portfolio for solid tumors allows Liminatus Pharma (LIMN) to scale patient reach while minimizing the specific risks associated with oncological development. This metric measures the actual cash flow from core operations before depreciation and taxes, helping investors assess the fundamental stability of the business by tracking absolute EBITDA deviations to avoid overpaying for the asset.
Pesaing Liminatus Pharma (LIMN)
NantKwest (IBRX) - Bathi sadurunge bunga, pajak, lan amortisasi|IMCR: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi JANX (januxrx.com)|RCUS: Bathi operasional EBITDA|ZYME - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Tango Pharma|Bathi operasional sadurunge ngurangi amortisasi Iovance Corp (IOVA)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Immatics N.V. (IMTX)|Bathi operasional sadurunge ngurangi amortisasi xencor.com XNCR|Compass Therapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA Replimune Group Inc REPL|LYEL - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|IPHA (Innate Pharma S.A) - Bathi operasional sadurunge amortisasi|pyxisoncology.com (PYXS) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Compugen (CGEN)|Bathi operasional sadurunge ngurangi amortisasi IOBT|STRO - Bathi operasional sadurunge potongan amortisasi|Bathi operasional sadurunge ngurangi amortisasi INKT (MiNK)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi HOWL|Bathi operasional EBITDA IMMX (Immix Biopharma)|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi ALXO|Cue Biopharma, Inc. - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi PDS Biotechnology|sonnetbio.com (SONN) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|MAIA Bio - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|LVTX (LAVA Therapeutics NV) - Bathi operasional EBITDA|Bathi operasional EBITDA nextcure.com|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Leap Therapeutics, Inc. (LPTX)|INTS: Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Sensei Biotherapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Theriva Corp (TOVX) - Bathi sadurunge bunga, pajak, lan amortisasi|GRTS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|KA: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|NEXI: Bathi operasional EBITDA|TSBX - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Vaccinex, Inc|Bathi operasional sadurunge ngurangi amortisasi Harpoon Therapeutics Corp (HARP)
